Dolat Capital: Alkem Labs Posts In-Line Q2 Numbers, Upping The Ante With Biosimilars  
Tablets arranged for a photograph in Mumbai, India. (Photographer: Dhiraj Singh/Bloomberg)  

Dolat Capital: Alkem Labs Posts In-Line Q2 Numbers, Upping The Ante With Biosimilars  

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.